Clinical Trial Update: Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin

View source ↗

Summary

Trial update for the active surveillance program assessing safety and effectiveness of linagliptin in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)
• Trade name not provided

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2020-04-02